Spacer

Spacer

Lucero is from Mexico and lives with diabetic retinopathy. Initially Lucero was misdiagnosed with cataracts in 2005 and then later received a diagnosis of diabetic retinopathy.

“It’s hard to understand how much sight means to us until we realise we could lose it. I remember in 2005, the first day I saw stains in my vision – smears of orange spread across my view, wherever I looked. It took me a whole month to seek medical help.”lucero-diabetic-retinopathy

Thanakorn is 69 years of age and lives with age-related macular degeneration with a polypoidal choroidal vasculopathy complication, a common form of the retinal condition.

“When I first noticed my vision beginning to fail, I didn’t even tell my wife and daughters. I was very afraid of losing my sight completely; I didn’t want to share this burden with them. Now I accept that I am getting older, and I know that my condition is a result of ageing – it is a result of the long and happy life that I’m lucky enough to live.”

Dr. Nancy M. Holekamp is Director of Retina Services at the Pepose Vision Institute in St. Louis, Missouri, USA

“The practice of medicine is a very unique human interaction, and we are so lucky in the field of Ophthalmology that we can make a meaningful difference in the lives of people with low vision or visual impairment. We have made so much scientific progress in the treatment of retinal diseases in recent years, and I believe we can keep building on this momentum and continue advancing care for the millions of people impacted.”

Our unique Group structure combines the strengths of discovering and developing new therapeutics, with diagnostics, data analytics, and genomic profiling expertise, giving us a powerful platform of collective understanding.

Today sophisticated technologies and molecular insights are available. However discovering and developing novel medicines and diagnostic tests is still a very complex and time consuming undertaking.

This website contains information on products which is targeted to a wide range of audiences and could contain product details or information otherwise not accessible or valid in your country. Please be aware that we do not take any responsibility for accessing such information which may not comply with any legal process, regulation, registration or usage in the country of your origin.

you go to an external page